Meet Linda. She is a five-year triple-negative breast cancer (TNBC) survivor and here to give advice to women diagnosed with TNBC. About 10 percent of women with breast cancer are diagnosed with TNBC, and African-American women are three-times more likely to have it.
TNBC grows quickly and is harder to treat than other types of breast cancer. That’s why our cancer experts worked with the National Association of Chronic Disease Directors, the Centers for Disease Control and Kognito to develop a brand new mobile app that helps newly diagnosed breast cancer patients learn about their treatment options.
“Talk to Someone: Triple Negative Breast Cancer” is an interactive and state-of-the-art tool that was developed using artificial intelligence engineering, to deliver a computer-animated conversational simulation tool. The app features an avatar character named Linda, who is a triple negative breast cancer survivor, and allows newly diagnosed patients to explore thousands of different conversational pathways.
Users lead the conversation by posing their questions about TNBC, chemotherapy, life during treatment, and survivorship to Linda. Cancer diagnosis often is overwhelming and confusing, and it can generate a flood of questions, concerns, and anxiety. This tool allows patients to spend time asking the computer the questions they may not have time to ask their own physician or caregiver. The objectives of the conversation are for patients to better understand their diagnosis, better understand advantages of chemotherapy, and to know what to expect from treatment, in order to raise motivation to pursue chemotherapy.
For more information or to download the app, visit: https://simulations.kognito.com/tnbc